You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
New cellular and molecular spatial biology methods, companies, and product offerings have made this area one of the hottest in the life science market.
Early data around an initial composite assay showed it can predict immunooncology drug responses more accurately than tumor mutational burden.
Called the COVID Bubble Test, the UK-based service allows the testing of up to 10 people on a single cartridge for £100, or £10 per person.
The next-generation sequencing-based panel comprises more than 50 genes and disorders known to cause hereditary anemias, such as pyruvate kinase deficiency.
The firm is also pursuing advances in its manufacturing and ordering processes that it says will help it scale to $500 million in annual revenues.
The company this month launched a lower priced benchtop instrument and a more versatile flagship product as well as a new intracellular protein assay.
Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.
The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.
The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.
In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.